PureTech Health Aktie
| 1,44EUR | 0,02EUR | 1,41% |
WKN DE: A14VK6 / ISIN: GB00BY2Z0H74
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. GBP) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 370 | 321 | 272 | 308 | 227 |
| Summe Anlagevermögen | 328 | 263 | 272 | 173 | 171 |
| Summe Aktiva | 698 | 584 | 544 | 481 | 398 |
Bilanz (in Mio. GBP) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 267 | 129 | 185 | 155 | 170 |
| Summe Eigenkapital | 431 | 455 | 359 | 326 | 227 |
| Summe Passiva | 698 | 584 | 544 | 481 | 398 |
Adresse
| 6 Tide Street, 02210 Boston | |
| Telefon | +1 (617) 482-2333 |
| Fax | +1 (617) 482-3337 |
| Internet | http://puretechhealth.com |
Management
|
Aleksandra Filipovic
Head-Oncology |
|
Allison Mead Talbot
VP-Communications & Investor Relations |
|
Anita Terpstra
Senior Vice President-Intellectual Property |
|
Charles Sherwood
Secretary & General Counsel |
|
Eric Elenko
President |
|
Frank Salisbury
Senior VP-Commercial & Product Strategy |
|
John L. LaMattina
Senior Independent Non-Executive Director |
|
Kiran Mazumdar-Shaw
Independent Non-Executive Director |
|
Michael Inbar
Chief Accounting Officer |
|
Michele A. M. Holcomb
Independent Non-Executive Director |
|
Robert S. Langer
Non-Executive Director |
|
Robert William Henry Lyne
Chief Executive Officer & Director |
|
Sharon Barber-Lui
Chairman |
|
Sharon L. Mates
Director |
|
Spencer Ball
Executive Vice President-Human Resources |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.